Anti-viral compounds
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
Abbott Laboratories
C A A A A
C07D A61P A61P A61P A61P
inventional inventional inventional inventional inventional
Liangjun Christopher E. Todd W. Darold L. Curt S. Jason P. Allan C. David A. Akteruzzaman Wenping Dale J. Robert J. Michael D. Sherie V. L. Tami J. Hongmei Rong Rolf David D. Nobuhiko
Lu Motter Rockway Madigan Cooper Shanley Krueger Betebenner Molla He Kempf Carrick Tufano Masse Pilot-Matias Mo Zhang Wagner Anderson Iwasaki